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We report the first cases of human infection by
Rickettsia felis in the Canary Islands. Antibodies against R.
felis were found in 5 adsorbed serum samples from 44
patients with clinically suspected rickettsiosis by Western
blot serology. Fleas from 1 patient’s dog were positive for
R. felis by polymerase chain reaction.
R
ickettsia felis is an intracellular bacterium (genus
Rickettsia, spotted fever group [SFG]) (1,2). Its bio-
logical cycle involves the cat flea (Ctenocephalides felis)
as the main vector (3). R. felis has been found in C. felis
and C. canis in the Americas, Europe, Africa, Asia, and
Oceania (1,3–6). Human disease caused by R. felis was
unknown until 1994 (4). Since then, R. felis infection has
been reported in Mexico (3 patients) (7), Germany (1
patient) (8), Brazil (2 patients) (1), and France (2 patients)
(1). The clinical manifestations of the disease include high
fever, rash, and elevation of liver enzymes (1,4,7).
Exposure to fleas or to flea-prone animals is sometimes
recorded (7,8). 
On the Canary Islands (Atlantic islands of Spain),
autochthonous cases of murine typhus have been reported
(9). Although we suspected that some patients with a clin-
ical picture of murine typhus actually had R. felis infection,
we were not able to confirm this hypothesis. Therefore, 44
serum samples from 44 patients from the Canary Islands
with suspected murine typhus were sent to the Unité des
Rickettsies in Marseille, France, for specific serologic
tests. Here, we describe the first 5 human infections caused
by R. felis on the Canary Islands. 
The Study
Forty-four patients were recruited for a prospective
study of fever of intermediate duration (i.e., fever without
focal symptoms lasting 7–28 days). Demographic, clinical,
and laboratory data were collected for all patients. Chest
radiographs and blood and urine cultures were taken.
Antibodies against R. typhi were tested by direct immuno-
fluorescence test (bioMérieux, Marcy L’Etoile, France) in
the Canary Islands. Among the 44 patients, 24 showed a
positive serologic result. Antibodies against other agents
(Coxiella burnetii,  R. conorii,  Leptospira spp., Epstein-
Barr virus, cytomegalovirus, HIV, and hepatitis B virus)
were also tested; all were negative.
To search for evidence of infection with R. felis, all
serologic results were confirmed by microimmunofluores-
cence (MIF) in France, as previously described (10).
Systematic testing of SFG rickettsia antigens present in
Europe and Africa was performed in parallel. The MIF
procedure was followed by the use of Western blot and
cross-adsorption studies. An immunofluorescence assay
was considered positive if immunoglobulin G (IgG) titers
were >1:64 or if IgM titers were >1:32. When cross-reac-
tions were noted between the rickettsial antigens, the
analysis comprised 3 steps. First, a rickettsial antigen was
considered to represent the agent of infection when IgG or
IgM antibody titers against this antigen were >2 serial dilu-
tions higher than titers of IgG or IgM antibody against
other rickettsial antigens (11). Second, when the difference
in titers between R. felis and other antigens was <2 dilu-
tions, Western blot assays were performed. A rickettsial
antigen was considered the agent of infection when sera
reacted only against the specific protein of this antigen.
Expected molecular masses of the specific proteins were
≈125 kDa for R. typhi and 31 kDa for R. felis. Finally,
when Western blot assays were not diagnostic, cross-
adsorption studies were performed, as previously
described (12). Specific diagnosis criteria after cross-
adsorptions studies included a Western blot assay that
showed exclusive reactivity with specific proteins of a sole
agent. If reactivity with the 2 tested agents was still
observed, diagnosis of an indeterminate rickettsial disease
was made. With this strategy, patients were classified by 3
types: R. felis infection, R. typhi infection, and indetermi-
nate rickettsial disease. 
Five fleas from the dog of 1 R. felis–infected patient
were tested by polymerase chain reaction (PCR) (3). DNA
was extracted and amplified with primers that targeted the
citrate synthase sequence, as previously described (3). For
negative controls, we used sterile water and infection-free
fleas previously tested in our laboratory; both negative
controls were tested after every 7 samples. Amplicons
were separated by electrophoresis on 1% agarose gels and
then purified by using a QIAquick PCR purification kit
(Qiagen, Hilden, Germany), as described by the manufac-
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damine terminator-cycle sequencing kit (PE Applied
BioSystems, Courtabeuf, France), as described by the
manufacturer. The sequences obtained were compared
with those available in the GenBank DNA database by
using the program Basic Local Alignment Search Tool
(BLAST, version 2.0, National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov/BLAST/).
A rickettsial infection was diagnosed by using MIF for
31 of the 44 patients: 5 patients with the final diagnosis of
R. felis infection, 13 with the diagnosis of R. typhi infec-
tion, and 13 with the diagnosis of indeterminate rick-
ettsioses (Table). The diagnosis of R. felis infection was
based on Western blot results on adsorbed sera for all
patients. All the antibodies of these patients were removed
when the R. felis–adsorbed sera were analyzed with R.
typhi and R. felis antigens, whereas antibodies to R. felis
remained when the R. typhi–adsorbed sera were analyzed. 
Western blots performed with unadsorbed and adsorbed
sera are represented in the Figure. Features of patients are
indicated in the online appendix (http://www.cdc.gov/
ncidod/EID/vol11no12/05-0711_app.htm). Some differ-
ences were found between groups. The interval between
the beginning of clinical signs and symptoms and evalua-
tion was significantly more prolonged in the R. felis group
than others. In the R. typhi group, odynophagia, cough, and
rash were more frequent. When we compared biologic
data, no difference was observed between R. typhi and
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the latter group. Finally, 2 PCR products were obtained
and sequenced from 2 fleas. Both sequences were 100%
similar to R. felis citrate synthase gene in GenBank acces-
sion no. AF210692. No fleas were positive for R. typhi.
Amplification was unsuccessful in all negative controls.
Conclusions
In the past 10 years, application of molecular tools has
resulted in discovery of several new species of pathogenic
rickettsiae, including R. felis. Since then, this bacterium
was cultivated, and its genome was sequenced (1,13). Its
pathogenic role was recently demonstrated in patients with
serologic evidence of infection in Brazil, France, and
Germany (1). R. felis DNA has also been detected in sera
in Texas, Mexico, Brazil, and Germany (1,4,8,14).
Autochthonous human rickettsioses that occur in the
Canary Islands include murine typhus; SFG infections
have never been reported (9). We diagnosed 5 cases of
acute R. felis infection (15). The clinical picture is global-
ly similar to murine typhus (4). However, the R. felis infec-
tion in our study seemed to be milder, and no skin rash was
observed. The incidence of R. felis infection in the Canary
Islands is probably underestimated; therefore, serologic
tests for R. felis should be performed in patients with pro-
longed fever or suspected rickettsioses. 
Cross-reactions in serologic testing for R. felis are
unpredictable (3). In our study, patients with R. felis infec-
tion more frequently had high antibody titers (IgM >1:32
and IgG >1:64) to R. conorii and R. typhi (2 of 5 patients)
than did patients with R. typhi infection (0 of 13). On the
basis of R. felis data, we conclude that patients with R. felis
infection may have no cross-reactivity with other rickettsi-
ae, cross-reactivity with SFG rickettsiae, or cross-reactivi-
ty with both SFG rickettsiae and R. typhi. Genetic support
for cross-reactivity with R. conorii is plausible because
most membrane proteins of SFG and R. felis are extreme-
ly close (surface cell antigen [Sca] family). Genome analy-
sis showed that several genes were present in R. felis and
R. typhi and absent for other SFG, which could explain the
cross-reactivity between R. felis and R. typhi (13). Finally,
if <2-fold differences in IgG/IgM titers between R. felis
and other SFG and typhus group rickettsiae are observed,
only Western blot and cross-adsorptions will allow a spe-
cific diagnosis once reactivity has disappeared after
adsorption with R. felis antigen. By contrast, a band of ≈31
kDa for the R. felis antigen persists after adsorption with R.
conorii and R. typhi. 
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